Best TWAS P=7.55e-15 · Best GWAS P=2.67e-16 conditioned to 0.00179
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | ARHGDIB | 0.10 | 0.01 | enet | 27 | 0.01 | 3.6e-02 | -8.2 | 5.5 | 4.5e-08 | -0.68 | 0.02 | 0.95 | FALSE |
2 | GTEx | Artery Aorta | ARHGDIB | 0.10 | 0.06 | enet | 10 | 0.08 | 5.4e-05 | -6.5 | 6.4 | 1.3e-10 | -0.83 | 0.33 | 0.56 | FALSE |
3 | GTEx | Artery Aorta | C12orf60 | 0.16 | 0.10 | lasso | 6 | 0.13 | 1.4e-07 | 3.6 | 6.3 | 2.3e-10 | -0.65 | 0.04 | 0.95 | FALSE |
4 | GTEx | Artery Tibial | ARHGDIB | 0.07 | 0.02 | lasso | 7 | 0.02 | 6.8e-03 | -8.1 | 7.2 | 5.7e-13 | -0.85 | 0.04 | 0.93 | FALSE |
5 | GTEx | Brain Nucleus accumbens basal ganglia | RP11-174G6.5 | 0.23 | 0.13 | lasso | 4 | 0.11 | 8.9e-04 | -4.5 | 6.3 | 2.4e-10 | -0.77 | 0.03 | 0.87 | FALSE |
6 | GTEx | Nerve Tibial | MGP | 0.20 | 0.09 | enet | 35 | 0.10 | 9.7e-08 | -8.1 | 5.7 | 1.4e-08 | -0.74 | 0.03 | 0.97 | FALSE |
7 | GTEx | Nerve Tibial | RERG | 0.10 | 0.01 | enet | 18 | 0.01 | 7.3e-02 | -1.6 | 5.4 | 5.7e-08 | -0.47 | 0.04 | 0.66 | FALSE |
8 | GTEx | Thyroid | MGP | 0.11 | 0.04 | enet | 12 | 0.06 | 2.6e-05 | -7.5 | 7.0 | 1.9e-12 | -0.85 | 0.39 | 0.59 | FALSE |
9 | GTEx | Thyroid | ARHGDIB | 0.12 | 0.03 | enet | 20 | 0.02 | 7.4e-03 | -7.8 | 7.8 | 7.6e-15 | -0.83 | 0.06 | 0.89 | TRUE |
10 | GTEx | Thyroid | C12orf60 | 0.16 | 0.10 | enet | 9 | 0.12 | 8.1e-10 | 3.3 | 5.8 | 5.1e-09 | -0.62 | 0.78 | 0.22 | FALSE |
11 | METSIM | Adipose | ERP27 | 0.07 | 0.04 | blup | 379 | 0.06 | 1.7e-09 | -6.5 | 5.6 | 2.4e-08 | -0.70 | 0.67 | 0.33 | FALSE |
12 | METSIM | Adipose | MGP | 0.04 | 0.04 | bslmm | 359 | 0.04 | 6.2e-07 | -7.4 | 6.8 | 1.3e-11 | -0.91 | 0.03 | 0.97 | FALSE |
13 | NTR | Blood | ARHGDIB | 0.01 | 0.00 | blup | 377 | 0.00 | 5.6e-02 | -6.2 | 5.9 | 3.4e-09 | -0.80 | 0.09 | 0.66 | FALSE |
14 | YFS | Blood | ERP27 | 0.30 | 0.41 | enet | 31 | 0.42 | 3.1e-152 | -5.8 | 6.3 | 3.5e-10 | -0.83 | 1.00 | 0.00 | FALSE |
15 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | ERP27 | 0.07 | 0.03 | enet | 17 | 0.04 | 1.6e-04 | -5.9 | 5.5 | 4.7e-08 | -0.66 | 0.20 | 0.49 | FALSE |
16 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ERP27 | 0.04 | 0.09 | lasso | 5 | 0.09 | 2.8e-17 | -6.2 | 6.6 | 4.0e-11 | -0.84 | 0.98 | 0.02 | FALSE |
17 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | ERP27 | 0.09 | 0.14 | lasso | 2 | 0.12 | 1.7e-06 | -6.2 | 6.3 | 3.2e-10 | -0.81 | 0.30 | 0.68 | FALSE |
18 | The Cancer Genome Atlas | Esophageal Carcinoma | ERP27 | 0.10 | 0.12 | blup | 75 | 0.08 | 1.5e-03 | -5.8 | 6.6 | 5.5e-11 | -0.85 | 0.04 | 0.78 | FALSE |
19 | The Cancer Genome Atlas | Glioblastoma Multiforme | ERP27 | 0.18 | 0.07 | blup | 76 | 0.11 | 2.7e-04 | -6.5 | 6.9 | 5.9e-12 | -0.79 | 0.09 | 0.62 | FALSE |
20 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | ERP27 | 0.10 | 0.18 | lasso | 6 | 0.18 | 1.2e-19 | -6.4 | 6.5 | 7.0e-11 | -0.86 | 0.96 | 0.04 | FALSE |
21 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ERP27 | 0.07 | 0.09 | blup | 73 | 0.09 | 4.8e-10 | -5.8 | 6.0 | 1.5e-09 | -0.85 | 0.79 | 0.21 | FALSE |
22 | The Cancer Genome Atlas | Lung Adenocarcinoma | ERP27 | 0.15 | 0.28 | lasso | 6 | 0.28 | 8.3e-33 | -6.2 | 6.4 | 2.0e-10 | -0.81 | 1.00 | 0.00 | FALSE |
23 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | ERP27 | 0.17 | 0.24 | enet | 13 | 0.25 | 6.7e-28 | -6.1 | 6.3 | 3.1e-10 | -0.84 | 1.00 | 0.00 | FALSE |
24 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C12orf60 | 0.10 | 0.01 | blup | 56 | 0.07 | 1.6e-05 | 3.3 | 5.2 | 1.7e-07 | -0.63 | 0.04 | 0.63 | FALSE |
25 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | ERP27 | 0.04 | 0.05 | enet | 12 | 0.04 | 1.0e-03 | -5.9 | 6.0 | 1.7e-09 | -0.82 | 0.19 | 0.45 | FALSE |
26 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | ERP27 | 0.14 | 0.12 | lasso | 5 | 0.11 | 2.9e-05 | -6.2 | 6.2 | 6.2e-10 | -0.80 | 0.22 | 0.65 | FALSE |
27 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ERP27 | 0.13 | 0.14 | lasso | 5 | 0.13 | 8.3e-14 | -5.8 | 6.0 | 2.0e-09 | -0.81 | 1.00 | 0.00 | FALSE |
28 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | ERP27 | 0.13 | 0.02 | blup | 74 | 0.06 | 1.4e-02 | -6.4 | 6.8 | 7.2e-12 | -0.82 | 0.03 | 0.65 | FALSE |
29 | The Cancer Genome Atlas | Stomach Adenocarcinoma | ERP27 | 0.07 | 0.03 | blup | 76 | 0.07 | 1.5e-05 | -2.0 | 5.7 | 1.6e-08 | -0.70 | 0.07 | 0.91 | FALSE |
30 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | ERP27 | 0.10 | 0.05 | lasso | 1 | 0.08 | 8.9e-04 | -6.2 | 6.2 | 4.3e-10 | -0.81 | 0.20 | 0.57 | FALSE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | ERP27 | 0.37 | 0.54 | enet | 18 | 0.55 | 2.3e-63 | -6.2 | 6.6 | 5.6e-11 | -0.83 | 1.00 | 0.00 | FALSE |